Over the past year, Novo Nordisk has introduced direct-to-consumer and cash-pay programs : Many uninsured or self-pay patients can access Ozempic or Wegovy for about $349$499 per month through manufacturer or pharmacy discount programs
Semaglutide, an FDA-approved weight loss medication, functions as a glucagon-like peptide-1 (GLP-1) analogue, aiding in weight management by stimulating insulin release and slowing stomach emptying
In India, GLP-1 drugs can only be prescribed by endocrinologists, internal medicine specialists, and cardiologists - they cannot be purchased over the counter
increased risk of kidney, pancreas and gastrointestinal problems Getty Images Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity